Epizódjegyzetek
In this solo episode of AI For Pharma Growth, Dr Andree Bates explores what health technology assessment bodies now expect when AI is used to generate, analyse or support evidence.
The episode looks at the emerging principles from NICE in England, CDA-AMC in Canada and the EU Joint Clinical Assessment framework. While none of these bodies has banned AI, Andree explains that organisations are increasingly expected to be able to justify where AI was used, how it was used, who was responsible for checking it and whether the process can be reconstructed.
She breaks the expectations into four…
Weboldal: podcasters.spotify.com

